HomeGH • NASDAQ
add
Guardant Health Inc
Previous close
$25.36
Day range
$24.50 - $25.57
Year range
$15.81 - $41.06
Market cap
3.04B USD
Avg Volume
2.06M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | 168.49M | 30.90% |
Operating expense | 202.88M | -3.25% |
Net income | -114.98M | 13.89% |
Net profit margin | -68.24 | 34.22% |
Earnings per share | -0.46 | 56.60% |
EBITDA | -88.97M | 28.08% |
Effective tax rate | -0.35% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.03B | 9.82% |
Total assets | 1.70B | 12.77% |
Total liabilities | 1.64B | 5.15% |
Total equity | 68.28M | — |
Shares outstanding | 122.37M | — |
Price to book | 45.29 | — |
Return on assets | -14.28% | — |
Return on capital | -17.02% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | -114.98M | 13.89% |
Cash from operations | -30.28M | 59.32% |
Cash from investing | 28.07M | -82.15% |
Cash from financing | -1.07M | -25.76% |
Net change in cash | -4.43M | -105.42% |
Free cash flow | -118.20M | -225.28% |
About
Guardant Health is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
Founded
2012
Headquarters
Website
Employees
1,774
